Additionally, we showed that mice lacking CAV1 developed more-severe hepatic steatosis when fed an HFD, demonstrating that CAV1 protects against the development of hepatic steatosis and hepatocyte injury that is involved in NAFLD. This evidence concerns the gene CAV1 and fatty liver disease.